Complete Filing Data
Jefferson Capital, Inc. / DE reported Stockholders Equity of $476.14 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Jefferson Capital, Inc. / DE did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income * | $188.0M | $128.9M | $111.5M |
| Servicing Revenue | $39.7M | $29.1M | $20.7M |
| Revenues | $613.3M | $433.3M | $323.1M |
| Portfolio Revenue After Recoveries | $566.4M | $395.9M | $293.6M |
| Other Selling General And Administrative Expense | $18.8M | $16.6M | $8.1M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $18.6M | -$14.0M | $8.3M |
| Operating Income Loss | $316.5M | $220.3M | $164.1M |
| Operating Expenses | $294.4M | $209.6M | $155.5M |
| Nonoperating Income Expense | -$98.1M | -$82.7M | -$43.5M |
| Interest Expense Nonoperating | $105.8M | $77.2M | $48.1M |
| Income Tax Expense Benefit | $30.5M | $8.7M | $9.0M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $218.4M | $137.6M | $120.6M |
| Credit Card Revenue | $7.2M | $8.3M | $8.8M |
| Comprehensive Income Net Of Tax | $206.6M | $114.9M | $119.8M |
| Income Taxes Paid Net | $8.4M | $8.7M | $9.0M |
| Deferred Income Tax Liabilities Net | $102.0M | $2.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Net Income * | $38.4M | $47.7M | $36.9M | $32.2M |
| Servicing Revenue | $9.4M | $10.5M | $7.6M | $7.1M |
| Revenues | $150.8M | $152.7M | $110.6M | $103.8M |
| Portfolio Revenue After Recoveries | $139.7M | $140.4M | $100.9M | $94.7M |
| Other Selling General And Administrative Expense | $4.2M | $5.0M | $2.1M | $1.9M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$5.0M | $14.4M | $4.9M | -$3.1M |
| Operating Income Loss | $70.0M | $86.6M | $59.4M | $55.1M |
| Operating Expenses | $80.2M | $65.5M | $50.3M | $47.7M |
| Nonoperating Income Expense | -$24.5M | -$24.7M | -$20.2M | -$21.1M |
| Interest Expense Nonoperating | $26.5M | $25.8M | $19.8M | $18.2M |
| Income Tax Expense Benefit | $7.2M | $14.3M | $2.4M | $1.9M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $45.5M | $61.9M | $39.2M | $34.1M |
| Credit Card Revenue | $1.8M | $1.8M | $2.0M | $2.1M |
| Comprehensive Income Net Of Tax | $33.3M | $62.1M | $41.7M | $29.0M |
| Income Taxes Paid Net | ||||
| Deferred Income Tax Liabilities Net | $98.9M | $94.1M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Stockholders Equity * | $476.1M | $382.5M | $303.6M | $214.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $47.6M | $38.2M | $20.6M | $15.2M |
| Goodwill | $58.0M | $57.7M | $57.2M | |
| Dividends Common Stock | $63.5M | $36.0M | $30.6M | |
| Restricted Cash | $24.3M | $2.7M | $6.2M | |
| Cash And Cash Equivalents At Carrying Value | $23.2M | $35.5M | $14.4M | |
| Notes Payable | $1.41B | $1.19B | ||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $566.0K | $1.8M | $2.4M | |
| Repayments Of Notes Payable | $969.3M | $650.4M | $328.4M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $9.3M | $17.6M | $5.4M | |
| Retained Earnings Accumulated Deficit | $522.6M | $398.1M | ||
| Property Plant And Equipment Net | $1.7M | $2.3M | ||
| Other Liabilities | $4.2M | $4.9M | ||
| Other Intangible Assets Net | $6.5M | $10.2M | ||
| Other Assets | $16.3M | $14.4M | ||
| Liabilities And Stockholders Equity | $2.09B | $1.65B | ||
| Liabilities | $1.61B | $1.27B | ||
| Assets | $2.09B | $1.65B | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $3.0M | -$15.6M | ||
| Accounts Receivable Net | $12.2M | $16.5M | ||
| Accounts Payable And Accrued Liabilities Excluding Tax Liabilities | $95.2M | $70.0M | ||
| Common Stock Value | $6.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Stockholders Equity * | $437.4M | $410.8M | $434.6M | $384.5M | $362.8M | $333.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $46.1M | $55.5M | $21.4M | $13.5M | ||
| Goodwill | $57.9M | $58.0M | $58.1M | $58.0M | ||
| Dividends Common Stock | $15.5M | $16.4M | $20.0M | |||
| Restricted Cash | $3.8M | $3.8M | $3.1M | $3.1M | ||
| Cash And Cash Equivalents At Carrying Value | $42.3M | $51.7M | $18.3M | $10.5M | ||
| Notes Payable | $1.18B | $1.18B | $948.0M | $845.0M | ||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | ||||||
| Repayments Of Notes Payable | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | ||||||
| Retained Earnings Accumulated Deficit | $500.4M | $477.6M | ||||
| Property Plant And Equipment Net | $1.9M | $2.3M | ||||
| Other Liabilities | $4.6M | $4.9M | ||||
| Other Intangible Assets Net | $7.3M | $8.2M | ||||
| Other Assets | $15.5M | $9.2M | ||||
| Liabilities And Stockholders Equity | $1.80B | $1.77B | ||||
| Liabilities | $1.37B | $1.36B | ||||
| Assets | $1.80B | $1.77B | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$2.3M | $2.7M | ||||
| Accounts Receivable Net | $17.3M | $20.4M | ||||
| Accounts Payable And Accrued Liabilities Excluding Tax Liabilities | $78.3M | |||||
| Common Stock Value | $6.0K | $6.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Increase Decrease In Recoveries | -$6.0M | $419.0K | $13.0M |
| Proceeds From Notes Payable | $1.19B | $1.08B | $654.7M |
| Payments Of Dividends | $63.5M | $36.0M | $30.6M |
| Payments Of Debt Issuance Costs | $15.3M | $7.3M | $5.9M |
| Net Cash Provided By Used In Operating Activities | $268.8M | $168.2M | $120.2M |
| Net Cash Provided By Used In Investing Activities | -$401.9M | -$542.4M | -$403.4M |
| Net Cash Provided By Used In Financing Activities | $149.7M | $388.8M | $289.9M |
| Increase Decrease In Other Operating Assets | $1.8M | $435.0K | $26.2M |
| Increase Decrease In Deferred Tax | $21.5M | -$527.0K | -$754.0K |
| Increase Decrease In Accounts Receivable | -$4.6M | $7.3M | -$17.9M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $25.5M | $37.2M | $9.0M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$7.3M | $3.0M | -$1.2M |
| Depreciation Depletion And Amortization | $5.3M | $2.6M | $2.4M |
| Proceeds From Issuance Of Common Stock | $10.0M | $0.00 | |
| Increase Decrease In Deferred Tax Liability From Reorganization | $79.5M | $0.00 | |
| Share Based Compensation | $17.2M | $0.00 | |
| Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition | $17.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Increase Decrease In Recoveries | -$494.0K | -$1.6M | -$1.7M | $41.0K |
| Proceeds From Notes Payable | ||||
| Payments Of Dividends | ||||
| Payments Of Debt Issuance Costs | ||||
| Net Cash Provided By Used In Operating Activities | ||||
| Net Cash Provided By Used In Investing Activities | ||||
| Net Cash Provided By Used In Financing Activities | ||||
| Increase Decrease In Other Operating Assets | ||||
| Increase Decrease In Deferred Tax | ||||
| Increase Decrease In Accounts Receivable | ||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | ||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | ||||
| Depreciation Depletion And Amortization | ||||
| Proceeds From Issuance Of Common Stock | ||||
| Increase Decrease In Deferred Tax Liability From Reorganization | ||||
| Share Based Compensation | ||||
| Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition | $8.9M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Common Stock Shares Outstanding | 58.3M | 0.00 |
| Common Stock Shares Issued | 58.3M | 0.00 |
| Common Stock Shares Authorized | 330.0M | 0.00 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 30.0M | |
| Weighted Average Number Of Diluted Shares Outstanding | 30.0M | |
| Earnings Per Share Diluted | $5.64 | |
| Earnings Per Share Basic | $5.64 | |
| Common Stock Dividends Per Share Declared | $0.98 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 |
|---|---|---|
| Common Stock Shares Outstanding | 58.3M | 58.3M |
| Common Stock Shares Issued | 58.3M | 58.3M |
| Common Stock Shares Authorized | 330.0M | 64.7M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 58.3M | 2.6M |
| Weighted Average Number Of Diluted Shares Outstanding | 58.3M | 2.8M |
| Earnings Per Share Diluted | $0.59 | $16.76 |
| Earnings Per Share Basic | $0.59 | $18.61 |
| Common Stock Dividends Per Share Declared | $0.24 | $0.25 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Servicing Expenses | $187.2M | $130.9M | $101.7M |
| Salaries And Wages | $64.6M | $48.1M | $36.5M |
| Provision For Loan Losses Expensed | $2.4M | $3.5M | $3.5M |
| Professional Fees | $18.6M | $11.4M | $6.8M |
| Portfolio Income | $560.4M | $396.3M | $306.5M |
| Foreign Currency Transaction Gain Loss Before Tax | $7.7M | -$5.5M | $4.6M |
| Depreciation And Amortization | $5.3M | $2.6M | $2.4M |
| Amortization Of Financing Costs | $6.2M | $4.3M | $2.9M |
| Provision For Doubtful Accounts | $2.4M | $3.5M | $3.5M |
| Interest Paid Net | $95.5M | $58.1M | $45.1M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | -$75.5M | ||
| Stock Issued During Period Value New Issues | $8.7M | ||
| Additional Paid In Capital | -$49.5M | ||
| Purchases Of Or Proceeds From Property And Equipment Net | $1.1M | $6.2M | $1.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Servicing Expenses | $47.6M | $43.5M | $33.2M | $30.8M |
| Salaries And Wages | $23.3M | $6.3M | $12.6M | $12.3M |
| Provision For Loan Losses Expensed | $569.0K | $560.0K | $867.0K | $983.0K |
| Professional Fees | $3.7M | $9.4M | $1.9M | $2.1M |
| Portfolio Income | $139.2M | $138.9M | $99.3M | $94.7M |
| Foreign Currency Transaction Gain Loss Before Tax | $1.9M | $1.1M | -$440.0K | -$2.9M |
| Depreciation And Amortization | $1.4M | $1.3M | $548.0K | $559.0K |
| Amortization Of Financing Costs | $1.5M | $1.4M | $1.1M | $1.1M |
| Provision For Doubtful Accounts | ||||
| Interest Paid Net | ||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | -$101.0K | -$78.2M | ||
| Stock Issued During Period Value New Issues | $8.7M | |||
| Additional Paid In Capital | -$60.7M | -$69.5M | ||
| Purchases Of Or Proceeds From Property And Equipment Net |
Most recent annual filing with the SEC: March 13, 2026
Data sourced from SEC EDGAR public filings as of August 8, 2026.